Search by Drug Name or NDC
NDC 80725-0011-30 Lunesta 2 mg/1 Details
Lunesta 2 mg/1
Lunesta is a ORAL TABLET, COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Waylis Therapeutics LLC. The primary component is ESZOPICLONE.
MedlinePlus Drug Summary
Eszopiclone is used to treat insomnia (difficulty falling asleep or staying asleep). Eszopiclone is in a class of medications called hypnotics. It works by slowing activity in the brain to allow sleep.
Related Packages: 80725-0011-30Last Updated: 05/26/2024
MedLinePlus Full Drug Details: Eszopiclone
Product Information
| NDC | 80725-0011 |
|---|---|
| Product ID | 80725-011_2c91f978-7c47-4f1d-8523-417d038c5030 |
| Associated GPIs | |
| GCN Sequence Number | 058483 |
| GCN Sequence Number Description | eszopiclone TABLET 2 MG ORAL |
| HIC3 | H2E |
| HIC3 Description | SEDATIVE-HYPNOTICS,NON-BARBITURATE |
| GCN | 23926 |
| HICL Sequence Number | 026791 |
| HICL Sequence Number Description | ESZOPICLONE |
| Brand/Generic | Brand |
| Proprietary Name | Lunesta |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ESZOPICLONE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, COATED |
| Route | ORAL |
| Active Ingredient Strength | 2 |
| Active Ingredient Units | mg/1 |
| Substance Name | ESZOPICLONE |
| Labeler Name | Waylis Therapeutics LLC |
| Pharmaceutical Class | n/a |
| DEA Schedule | CIV |
| Marketing Category | NDA |
| Application Number | NDA021476 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 80725-0011-30 (80725001130)
| NDC Package Code | 80725-011-30 |
|---|---|
| Billing NDC | 80725001130 |
| Package | 30 TABLET, COATED in 1 BOTTLE (80725-011-30) |
| Marketing Start Date | 2023-08-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |